BlackRock Fund Advisors - TRANSCEPT PHARMACEUTICALS IN ownership

TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 35 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2014$90,000
-5.3%
44,578
-6.8%
0.00%
Q2 2014$95,000
-33.6%
47,825
+2.9%
0.00%
Q1 2014$143,000
+4.4%
46,457
+13.8%
0.00%
Q4 2013$137,000
+10.5%
40,814
+4.4%
0.00%
Q3 2013$124,000
+13.8%
39,104
+8.5%
0.00%
Q2 2013$109,00036,0260.00%
Other shareholders

There were no reported owners of TRANSCEPT PHARMACEUTICALS IN in Q3 2014.

NameSharesValueWeighting ↓
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders